Literature DB >> 9142975

Predictive factors for response to cytotoxic treatment in advanced breast cancer: a review.

J Sjöström1, C Blomqvist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9142975     DOI： 10.3109/02841869609083978

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  3 in total

1.  Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer.

Authors:  Reva K Basho; Clinton Yam; Michael Gilcrease; Rashmi K Murthy; Thorunn Helgason; Daniel D Karp; Funda Meric-Bernstam; Kenneth R Hess; Vicente Valero; Constance Albarracin; Jennifer K Litton; Mariana Chavez-MacGregor; David Hong; Razelle Kurzrock; Gabriel N Hortobagyi; Filip Janku; Stacy L Moulder
Journal:  Oncologist       Date:  2018-08-23

2.  Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials.

Authors:  S-E Al-Batran; M Güntner; C Pauligk; M Scholz; R Chen; B Beiss; S Stopatschinskaja; W Lerbs; N Harbeck; E Jäger
Journal:  Br J Cancer       Date:  2010-10-26       Impact factor: 7.640

3.  A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer.

Authors:  J Sjöström; S Krajewski; K Franssila; E Niskanen; V M Wasenius; S Nordling; J C Reed; C Blomqvist
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.